Related Experiment Video
Updated: Apr 23, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Cyclin D1 acts as a barrier to pluripotent reprogramming by promoting neural progenitor fate commitment
Chih-Lung Chen1, Liang-Jie Wang2, Yu-Ting Yan3
1Graduate Institute of Life Science, National Defense Medical Center, Taipei 114, Taiwan; Genomics Research Center, Academic Sinica, Taipei 115, Taiwan.
Abstract:
A short G1 phase is a characteristic feature of the cell cycle structure of pluripotent cells, and is reestablished during Yamanaka factor-mediated pluripotent reprogramming. How cell cycle control is adjusted to meet the requirements of pluripotent cell fate commitment during reprogramming is less well understood. Elevated levels of cyclin D1 were initially found to impair pluripotency maintenance. The current work further identified Cyclin D1 to be capable of transcriptionally upregulating Pax6, which promoted reprogramming cells to commit to a neural progenitor fate rather than a pluripotent cell fate. These findings explain the importance of reestablishment of G1-phase restriction in pluripotent reprogramming.
More Related Videos
Related Concept Videos
Somatic to iPS Cell Reprogramming
Methods of Nuclear Reprogramming
Negative Regulator Molecules
Maintenance of the ES Cell State
Positive Regulator Molecules
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...

